Physician profile
Patricia P Chen
NPI 1316968886
$3,351.42
in general payments reported to CMS, 2019-2025
34 companies · $677 in 2025
The $677 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $754 · 2020: $129 · 2021: $336 · 2022: $444 · 2023: $331 · 2024: $679 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,634 · Education: $53.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,634.19 |
| Education | $53.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $494.72 | 2019-2023 | Lo Loestrin Fe |
| Gynesonics, INC. | $266.93 | 2022 | |
| Sumitomo Pharma America, INC. | $191.07 | 2023-2025 | Myfembree |
| Millicent US INC | $165.48 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Medicem INC. | $145.91 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $139.79 | 2023-2025 | |
| Astellas Pharma US INC | $137.10 | 2023-2025 | Veozah |
| Baxter Healthcare | $134.66 | 2025 | Perclot |
| Amag Pharmaceuticals, INC. | $130.21 | 2019 | |
| Caldera Medical, INC | $130.03 | 2024 | Desara |
| Therapeuticsmd, INC. | $122.79 | 2019-2020 | |
| Hologic Sales and Service, LLC | $120.88 | 2021-2025 | Aptima, Thinprep 2000 Processor |
| Coopersurgical, INC. | $112.18 | 2019-2025 | Paragard T 380a, Summit Doppler, Paragard T 380a |
| Biogen, INC. | $103.48 | 2025 | Zurzuvae |
| Pfizer INC. | $96.93 | 2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $87.20 | 2019-2025 | |
| Organon LLC | $80.78 | 2025 | |
| Radiometer America, INC | $80.58 | 2024 | |
| Allergan, INC. | $79.79 | 2019-2020 | |
| Exeltis, USA INC. | $70.83 | 2023-2025 | Slynd |
| Agile Therapeutics, INC. | $70.16 | 2021-2023 | Twirla |
| Myovant Sciences INC. | $63.27 | 2021-2022 | |
| Mimedx Group, INC. | $45.28 | 2025 | |
| Exact Sciences Corporation | $40.05 | 2025 | The Cologuard Plus Collection Kit |
| Channel Medsystems, INC. | $31.07 | 2023 | |
| Lupin INC. | $30.36 | 2019 | |
| Zyla Life Sciences, INC. | $27.95 | 2020 | |
| Smith+Nephew, INC. | $26.81 | 2021 | |
| Vertical Pharmaceuticals, LLC | $24.97 | 2019 | |
| Avion Pharmaceuticals | $24.38 | 2019-2022 | |
| Duchesnay USA Incorporated | $23.85 | 2019 | |
| Heron Therapeutics, INC. | $21.12 | 2024 | Zynrelef |
| Optumhealth Care Solutions, LLC | $17.51 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Merck Sharp & Dohme LLC | $13.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.